PALM CITY, FL--(Marketwire - February 04, 2013) - GelStat Corporation (PINKSHEETS: GSAC), a consumer healthcare company primarily focused on the development and marketing of over-the-counter (OTC) products for the safe and effective treatment of pain, inflammation and sleep disorders, announces that it has retained List Services Corp. ("LSC") to manage all branding and marketing efforts for GelStat Corporation and its products.
LSC is a direct marketing agency founded on providing its clients, customers, and partners with exceptional service and data. The company has evolved from a list management and brokerage house into a full service organization operating in every facet of direct marketing: list, database, online and email.
Gerald Kieft, CEO of GelStat, said, "After an extensive search for the right fit, I am extremely pleased to have List Services as GelStat's marketing partner. LSC and its team have a long-term proven track record of building and support leading brands including Fortune 100 media companies, healthcare organizations, publishers and retailers offering each insight on how the convergence of big data and technology is affecting their marketing efforts and sales channels. The Company's existing products, including GelStat Migraine and GelStat Sleep, have received a plethora of positive customer feedback over the years. Now that we have the right marketing team in place, I'm confident that we have the platform necessary to drive revenue and build shareholder value."
Charlie Tarzian, Chief Strategic Officer of LSC, said, "We are thrilled to be associated with such a quality organization as GelStat. The products speak for themselves -- and the testimonials, by real consumers, sealed the deal for us -- this is a great solution to some of life's most difficult conditions -- and we aim to drive awareness and education so that GelStat can become a household name."
The main points of the agreement include:
- LSC, as its marketing partner, will act as GelStat's in-sourced marketing services group to build its brand of healthcare products and driving demand for the product through a number of communications and media channels. This effort will be led by Charlie Tarzian acting as GelStat's Chief Marketing Officer.
- LSC will provide a full complement of services and provide GelStat with the necessary and appropriate resources to help design, build and implement integrated marketing programs that accomplish specifically defined goals set out by GelStat and agreed to by LSC.
- Services provided by LSC will include: strategic brand and communications channel planning, media planning and buying, media trafficking, creative services, data modeling and analytics, campaign management, reporting and reconciliation and any other relevant service that will be used and required to drive the GelStat brand and demand for the product set.
- LSC will deploy a hybrid model that will include a small, retained group of senior marketing professionals that will be responsible for the day-to-day running and managing of the business; and a project-based, as-needed staff of marketing specialists that will be called upon across the various stages of the relationship to perform specific tasks and functions.
Make sure you are first to receive timely information on GelStat Corporation when it hits the newswire. Sign up for GelStat's email news alert system today at: http://ir.stockpr.com/gelstat/request-information
Since 1980, LSC has combined "Big Data" with technology to offer go-to-market strategies for client marketing and sales channels.
LSC builds data management platforms that offer database marketing, social listening and dynamic content deployment that offer campaign management and workflow solutions that increase marketing's ROI.
Specialties: Marketing Automation, Big Data, Campaign Management, Workflow Management, eCommerce, Dynamic CMS, Database Marketing/DMP, Email Marketing/ESP, Social Marketing, Mobile, SEM, PPC, Intelligent Targeted Media (Facebook, LinkedIn, display), Self Service Publishing, Lead Generation/Nurturing. For more information, visit http://www.listservices.com.
ABOUT GELSTAT CORPORATION
GelStat Corporation is dedicated to providing safe and effective over-the-counter (OTC) treatments for pain, inflammation and sleep disorders. GelStat's first two products GelStat Migraine and GelStat Sleep are sold through direct-to-consumer channels as well as in a limited number of independent retailers and pharmacies. The Company also has a suite of additional healthcare products in various stages of development that address large consumer markets. For more information, visit www.gelstat.com.
Safe Harbor Statement
This press release and the shareholder letter contains forward-looking statements including pursuing strategic relationships, building and leveraging a direct-to consumer platform to launch new products, acquiring or licensing the rights to products with proven science, growing organically and achieving each of the goals mentioned above. Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects" and similar references to future periods.
Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include the failure of our products to be accepted, failure to obtain partners to market and distribute our products, unanticipated delays in launching website or failure of the website to generate revenues, our inability to find a target to acquire on mutually acceptable terms, and the inability to get our reports prepared and filed timely as a result of unforeseen audit issues.
Any forward-looking statement made by us in this press release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.